Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 10 (RPSAP10) is a processed pseudogene of the *RPSA* gene, part of a multicopy family including one functional *RPSA* gene and multiple pseudogenes in mammalian genomes. Unlike the functional *RPSA* gene that encodes a ribosomal protein and cell surface laminin receptor involved in various physiological and pathological processes, RPSAP10 does not produce a functional protein due to mutations like the lack of a start codon or frameshifts. Experimental analysis in sheep and comparative studies indicate that RPSAP10 is not expressed in tested tissues and has no demonstrated biological function. It is not considered a drug target or biomarker, nor is it involved in human disease. The reason for its characterization is primarily to distinguish true *RPSA* activity from pseudogenic interference in molecular or genetic assays.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein SA pseudogene 10 (RPSAP10).